Genetic alterations in primary breast cancer Robert Callahan 11th San Antonio Breast Cancer Symposium-Plenary Lecture Pages: 191 - 203
Exposure, susceptibility, and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence Nancy Krieger OriginalPaper Pages: 205 - 223
Treatment of stage III breast cancer William L. McGuireMartin D. AbeloffSandra M. Swain Viewpoints Pages: 225 - 235
Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer F. HabibollahiI. S. FentimanR. D. Rubens Report Pages: 237 - 241
Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer Aileen Burford-MasonGillian M. L. GyteSylvia M. Watkins Report Pages: 243 - 250
Beta-adrenergic receptors in DMBA-induced rat mammary tumors: Correlation with progesterone receptor and tumor growth Bianca MarchettiPaulo G. SpinolaFernand Labrie Report Pages: 251 - 263
Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: Antagonism by insulin Richard PoulinJean -Marc DufourFernand Labrie Report Pages: 265 - 276
Hereditary breast cancer and possible risk of mammography F. J. H. SluijterJ. W. KotenW. Den Otter Correspondence Pages: 277 - 277
Menstrual history and breast cancer surgery Scott A. GruberKristin L. NicholWilliam J. M. Hrushesky Correspondence Pages: 278 - 278
Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors J S Meyer Erratum Pages: 279 - 279